Drugs / ONO-7684
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03919890 | Jan → Aug 2019 | venous thromboembolism | Ono Pharmaceutical Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONO-7684 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03919890 ↗ |
| Known as | ONO-5450598 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5415591 ↗ |
| Modality | Small molecule | — CHEMBL5415591 ↗ |
| Route | Oral | “ONO-7684 is administered orally” NCT03919890 ↗ |